Home » Newsletters » BioWorld Science

BioWorld Science

March 19, 2007

View Archived Issues

NCX-4016 prevents endothelial dysfunction in intermittent claudication patients

HIV-specific T-cell responses seen with multiclade, multigene HIV vaccines

Anticancer compounds disclosed in recent patent literature

Recent patents disclose new therapeutic agents for sleep disorders and psychosis

Pegasys studied in difficult-to-treat hepatitis C patients

ZK-EPO reported highly effective in a breast cancer bone metastasis model

Ecopia BioSciences and Caprion complete business combination

Taribavirin studied in phase IIb trial for chronic hepatitis C

Novel TB vaccine shows promising immunogenicity in phase I trial

IMA-901 receives E.U. orphan drug status for renal cell cancer

Neose cleared to begin U.S. development of NE-180

Wyeth terminates SCOLR ibuprofen license

Abeille licenses AB-1001 emesis patch to SymBio for Japan and Pacific Rim countries

Vasostatin-Apo2L enters preclinical research

Trimeris regains rights to next-generation fusion inhibitors from Roche

Updated development status of Oxygent in China

Nippon Shinyaku and Teva terminate HMN-214 license agreement

Exelixis files IND for XL-147

Micromet grants Tracon rights to D93

Alkaline phosphatase shows benefit for patients with acute renal failure

Positive preclinical results of Colostrinin in mouse model of premature senescence

Losartan shows neuroprotection in a mouse model of Alzheimer's disease

First European launch for Dynepo

Soliris approved for paroxysmal nocturnal hemoglobinuria

GSK's novel BACE-1 inhibitor shows Abeta-lowering activity in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...